Table 1.
No. | Factors | References | Sulfiredoxin expression |
||
---|---|---|---|---|---|
Increase | No change | Decrease | |||
Chemopreventive agents | |||||
1 | Cinnamic aldehyde | [21] | ✓ | ||
2 | Maesopsin-4-O-β d-glucoside (TAT-2) | [22] | ✓ | ||
3 |
Nitrofurtimox, nitrofurtimox+ tetrathiomolybdate |
[23] | ✓ | ||
Hormones | |||||
4 | Luteinizing hormone | [32] | ✓ | ||
5 | Human chorionic gonadotropin | [32] | ✓ | ||
6 | Adrenocorticotropic hormone | [34] | ✓ | ||
7 | Dexamethasone | [34] | ✓ | ||
Pro-oxidants | |||||
8 | Diquat | [24] | ✓ | ||
9 | Ethanol | [25] | ✓ | ||
10 | Pyrazole | [26] | ✓ | ||
11 | Cadmium | [27] | ✓ | ||
12 | Copper | [28] | ✓ | ||
Antioxidants | |||||
13 | Sulforaphane and curcumin | [29] | ✓ | ||
14 | Roasted coffee extracts | [30] | ✓ | ||
15 | 3H-1,2-dithiole-3-thione (D3T) | [7] | ✓ | ||
16 | Rutin | [31] | ✓ | ||
17 | Tiron and diphenylene iodonium chloride | [32] | ✓ | ||
Exogenous factors | |||||
18 | Hyperoxia | [39] | ✓ | ||
19 | Interferon-γ | [35,36] | ✓ | ||
20 | Lipopolysaccharide | [34–37] | ✓ | ||
21 | Nitric oxide | [35] | ✓ | ||
22 | High cholesterol diet | [31] | ✓ | ||
Endogenous factors | |||||
23 | Circadian rhythm | [34] | ✓ | ✓ | |
Transcription factors | |||||
24 | Nrf2 | [27,29] | ✓ | ||
25 | Nf-κβ inhibitor (IMD-3054) | [28] | ✓ | ||
26 | RANKL | [29] | ✓ |